克隆性血液形成到克隆性细胞衰竭:揭开随时间推移的疾病演变
Kristina Kirschner1, Yael Kusne2, Catherine Cargo3
1Department Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA; Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
The Lancet. Haematology
|July 20, 2025
概括
克隆性血液形成,血液干细胞的突变,可以导致癌症. 了解其原因和进展是早期检测和更好的风险评估的关键.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 克隆性血液形成涉及血液干细胞的体质突变,导致克隆扩张.
- 与年龄相关的和治疗诱导的突变有助于克隆性血液形成,与瘤和心血管疾病有关.
- 意义不明的克隆细胞衰竭 (CCUS) 代表了髓状瘤的前体状态.
研究的目的:
- 审查当前关于克隆性血液形成和CCUS的知识.
- 为分子进化,诊断和风险评估提供见解.
- 突出影响血液瘤进展的因素.
主要方法:
- 对克隆性血液形成和CCUS现有文献的综述.
- 对推动克隆扩张的分子机制的分析.
- 对诊断和风险分层策略的评估.
主要成果:
- 克隆性血液形成与衰老,基因毒性暴露和骨髓衰竭综合征有关.
- CCUS是一个独特的实体,先于髓状瘤,具有可变的进展.
- 衰老和环境因素的相互作用影响了瘤的转变.
结论:
- 需要进一步的研究来完善风险分层和对克隆性血液形成和CCUS的监测.
- 了解分子进化对于开发向疗法至关重要.
- 改进的诊断对于早期发现和管理至关重要.
相关概念视频
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
12.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.9K
Overview of Hematopoiesis
4.8K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.8K
Production of Formed Elements
1.7K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


